The role of fibroblast growth factor receptor 4 (FGFR4) signaling in anti-EGFR resistance in colon cancer.

被引:0
|
作者
Cho, Sang Hee
Kim, Jo-Heon
Hong, Chang-Soo
Sun, Eun-Gene
Ryu, Kyung-Hyun
Hwang, Jun Eul
Bae, Woo Kyun
Chung, Ik-Joo
Bang, Hyun-Jin
机构
[1] Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea
[2] Chonnam Natl Univ, Hwasun Hosp, Dept Pathol, Hwasuneup, South Korea
[3] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea
[4] Chonnam Natl Univ, Med Sch, Gwangju, South Korea
[5] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea
基金
新加坡国家研究基金会;
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4060
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoter
    Yu, SJ
    Zheng, L
    Asa, SL
    Ezzat, S
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (03): : E490 - E495
  • [2] Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer
    R C Turkington
    D B Longley
    W L Allen
    L Stevenson
    K McLaughlin
    P D Dunne
    J K Blayney
    M Salto-Tellez
    S Van Schaeybroeck
    P G Johnston
    Cell Death & Disease, 2014, 5 : e1046 - e1046
  • [3] Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer
    Turkington, R. C.
    Longley, D. B.
    Allen, W. L.
    Stevenson, L.
    McLaughlin, K.
    Dunne, P. D.
    Blayney, J. K.
    Salto-Tellez, M.
    Van Schaeybroeck, S.
    Johnston, P. G.
    CELL DEATH & DISEASE, 2014, 5 : e1046 - e1046
  • [4] Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas
    La Rosa, S
    Sessa, F
    Colombo, L
    Tibiletti, MG
    Furlan, D
    Capella, C
    JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (01) : 37 - 41
  • [5] Fibroblast growth factor receptor 4 (FGFR4) G388R polymorphism in colorectal cancer
    Heinzle, C.
    Hunjadi, M.
    Erdem, Z.
    Staettner, S.
    Klimpfinger, M.
    Grasl-Kraupp, B.
    Holzmann, K.
    Grusch, M.
    Berger, W.
    Marian, B.
    EJC SUPPLEMENTS, 2010, 8 (07): : 108 - 108
  • [6] INHIBITION OF FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) SIGNALING ACTIVATES TUMOR INTERFERON (IFN) SIGNALING IN HEPATOCELLULAR CARCINOMA (HCC)
    Zhang, Nannan
    Chen, Zhui
    Shen, Bin
    Zhu, Zhixuan
    Shi, Jueping
    Zhang, Jiacheng
    Liang, Pan
    Wang, Jie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1027 - A1027
  • [7] Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer
    Heublein, Sabine
    Anglesio, Michael S.
    Marme, Frederik
    Kommoss, Stefan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (09) : 2251 - 2259
  • [8] Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer
    Sabine Heublein
    Michael S. Anglesio
    Frederik Marmé
    Stefan Kommoss
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2251 - 2259
  • [9] Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival
    Tiong, Kai Hung
    Tan, Boon Shing
    Choo, Heng Lungh
    Chung, Felicia Fei-Lei
    Hii, Ling-Wei
    Tan, Si Hoey
    Khor, Nelson Tze Woei
    Wong, Shew Fung
    See, Sze-Jia
    Tan, Yuen-Fen
    Rosli, Rozita
    Cheong, Soon-Keng
    Leong, Chee-Onn
    ONCOTARGET, 2016, 7 (36) : 57633 - 57650
  • [10] Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer
    Hong, Chang-Soo
    Sun, Eun-Gene
    Choi, Ji-Na
    Kim, Dae-Hwan
    Kim, Jo-Heon
    Ryu, Kyung-Hyun
    Shim, Hyun-Jeong
    Hwang, Jun-Eul
    Bae, Woo-Kyun
    Kim, Hyeong-Rok
    Kim, Kyung Keun
    Jung, Chaeyong
    Chung, Ik-Joo
    Cho, Sang-Hee
    CANCER SCIENCE, 2020, 111 (09) : 3268 - 3278